ponatinib
Showing 1 - 25 of 40
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)
Recruiting
- Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Imatinib
- +3 more
-
Frankfurt, GermanyDepartment of Medicine, Hematology and Oncology, Goethe Universi
Sep 24, 2023
Acute Lymphoblastic Leukemia, Leukemia Trial in Houston (Ponatinib, Venetoclax, Mini-hyper CVD)
Recruiting
- Acute Lymphoblastic Leukemia
- Leukemia
- Ponatinib
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Aug 23, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +6 more
- Decitabine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 31, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +7 more
- Blinatumomab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Leukemia, Myeloid, Chronic-Phase Trial in Germany (Ponatinib)
Active, not recruiting
- Leukemia, Myeloid, Chronic-Phase
- Ponatinib
-
Halle (Saale), Saxony-Anhalt, Germany
- +9 more
Sep 9, 2022
Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)
Recruiting
- Acute Lymphoblastic Leukemia
- Dasatinib
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Nov 28, 2022
CML Patients in the National Compassionate Program
Terminated
- Chronic Myeloid Leukemia
- Philadelphia Positive
- Ponatinib
-
Bari, Italy
- +9 more
Oct 24, 2022
Adenocarcinoma of the Lung, Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer Trial in Aurora
Completed
- Adenocarcinoma of the Lung
- +7 more
- Ponatinib
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Jan 19, 2022
Medullary Thyroid Cancer Trial (Ponatinib)
Withdrawn
- Medullary Thyroid Cancer
- Ponatinib
- (no location specified)
Oct 6, 2021
Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia Trial in Worldwide
Recruiting
- Acute Myeloid Leukemia
- +8 more
- Ponatinib
-
Ghent, Belgium
- +28 more
Nov 11, 2022
Philadelphia Chromosome Positive CML, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in France (Ponatinib, Imatinib)
Recruiting
- Philadelphia Chromosome Positive CML
- BCR-ABL Positive Chronic Myelogenous Leukemia
- Ponatinib
- Imatinib
-
Amiens, France
- +27 more
Dec 9, 2021
Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL), Ph+ Mixed Phenotype Acute Leukemia (MPAL),
Recruiting
- Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL)
- +2 more
- Ponatinib
- +2 more
-
Phoenix, Arizona
- +69 more
Aug 23, 2022
Philadelphia-Positive ALL, Acute Lymphoblastic Leukemia, in Relapse Trial in Italy (Ponatinib)
Recruiting
- Philadelphia-Positive ALL
- Acute Lymphoblastic Leukemia, in Relapse
- Ponatinib
-
Ancona, Italy
- +21 more
Jan 3, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +5 more
- Blinatumomab
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2022
Chronic Myeloid Leukemia, Chronic Phase, Adults Trial in Italy (Ponatinib)
Active, not recruiting
- Chronic Myeloid Leukemia
- +2 more
- Ponatinib
-
Alessandria, Italy
- +36 more
Jan 4, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +6 more
- Cyclophosphamide
- +12 more
-
Houston, TexasM D Anderson Cancer Center
Jan 31, 2022
Iclusig PMS in CML or Ph+ALL Patients
Recruiting
- Chronic Myeloid Leukemia
- Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
- Ponatinib
-
Busan, Korea, Republic ofKosin University Gaspel Hospital
Sep 16, 2021
Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,
Recruiting
- Lymphoblastic Leukemia
- +2 more
- Inotuzumab ozogamicin
- +7 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
May 16, 2022
Philadelphia Positive, BCR-ABL Positive, Acute Lymphoblastic Leukemia Trial in Italy (Ponatinib)
Completed
- Philadelphia Positive
- +2 more
- Ponatinib
-
Alessandria, Italy
- +41 more
Nov 18, 2021
Acute Lymphoblastic Leukemia, Adult Trial (Ponatinib, Blinatumomab, Imatinib)
Not yet recruiting
- Acute Lymphoblastic Leukemia, Adult
- Ponatinib
- +2 more
- (no location specified)
Dec 28, 2020
Myeloid Leukemia, Chronic, Chronic Phase Trial in Worldwide (Ponatinib)
Active, not recruiting
- Myeloid Leukemia, Chronic, Chronic Phase
- Ponatinib
-
Atlanta, Georgia
- +85 more
Jan 4, 2022
Chronic Myeloid Leukemia, Ph+ Acute Lymphoblastic Leukemia Trial in Worldwide (Ponatinib)
Completed
- Chronic Myeloid Leukemia
- Ph+ Acute Lymphoblastic Leukemia
- Ponatinib
-
St Leonards, New South Wales, Australia
- +41 more
Jan 18, 2021